In early January 2026, Erasca reported early clinical data showing confirmed and unconfirmed partial responses plus favorable safety and pharmacokinetics for its pan-RAS degrader ERAS-0015 and ...
An announcement from BridgeBio Oncology Therapeutics ( (BBOT)) is now available. On January 7, 2026, BridgeBio Oncology Therapeutics reported positive preliminary clinical data across all three of its ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
BBO-8520 monotherapy in patients with KRAS G12C non-small cell lung cancer (NSCLC) showed a 65% objective response rate (ORR) and a 66% 6-month progression-free survival (PFS), with 83% of patients ...
AllTranstek, a subsidiary of RAILTRAC, completed the acquisition of the assets of RAS Data Services (RAS), strengthening its position as a large non-leasing railcar management and consulting company.
The Rasmussen Reports daily Presidential Tracking Poll for Friday shows that 41% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-seven (57%) disapprove. The latest figures ...
USA: Wagon fleet management services company AllTranstek was the prevailing bidder for the assets of RAS Data Services at an auction concluded on December 11 2025. Darien, Illinois based RAS was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results